Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0DT2P
|
|||
| Former ID |
DIB008298
|
|||
| Drug Name |
Nafagrel
|
|||
| Synonyms |
Nafagrel hydrochloride; DP-1904; SR-96325
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Asthma [ICD-11: CA23; ICD-10: J45, J45.8; ICD-9: 493] | Discontinued in Phase 2 | [1] | |
| Company |
Daiichi Seiyaku Co Ltd
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C15H16N2O2
|
|||
| Canonical SMILES |
C1CC2=C(CC1CN3C=CN=C3)C=CC(=C2)C(=O)O
|
|||
| InChI |
1S/C15H16N2O2/c18-15(19)14-4-3-12-7-11(1-2-13(12)8-14)9-17-6-5-16-10-17/h3-6,8,10-11H,1-2,7,9H2,(H,18,19)
|
|||
| InChIKey |
VJJHOPPXRPHVCA-UHFFFAOYSA-N
|
|||
| CAS Number |
CAS 97901-21-8
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Isomerase unspecific (IsoM) | Target Info | Modulator | [2] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800000433) | |||
| REF 2 | FMLP actions and its binding sites in isolated human coronary arteries. J Mol Cell Cardiol. 1997 Mar;29(3):881-94. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.